Angelina Bellanton
About Angelina Bellanton
Angelina Bellanton serves as the Director of Legal and IP Operations at EyePoint Pharmaceuticals, bringing extensive experience in legal operations within the pharmaceutical sector. Her career includes roles at Ikena Oncology, Sumitomo Dainippon Pharma Oncology, and Sanofi, where she has successfully implemented Contract Lifecycle Management systems.
Work at EyePoint Pharmaceuticals
Angelina Bellanton serves as the Director of Legal and IP Operations at EyePoint Pharmaceuticals. She has held this position since 2024, contributing to the company's legal and intellectual property strategies. Her role involves overseeing legal operations and ensuring compliance with relevant regulations within the pharmaceutical sector. Based in Watertown, Massachusetts, she plays a critical role in supporting the company's objectives through effective legal management.
Previous Experience in Legal Operations
Prior to her current role, Angelina Bellanton worked at Ikena Oncology as the Associate Director of IP Operations and Research Contracts from 2023 to 2024. She also held the position of Legal Operations Manager at Sumitomo Dainippon Pharma Oncology from 2020 to 2021. Her experience includes significant roles at Sanofi as a Senior Patent Coordinator from 2014 to 2018 and as a Senior IP and Operations Paralegal at Sumitomo Dainippon Pharma Oncology from 2018 to 2020.
Education and Expertise
Angelina Bellanton earned her Bachelor of Arts in Legal Studies from the University of Massachusetts Amherst, completing her studies from 1994 to 1999. She possesses expertise in intellectual property administration and docketing, which has been instrumental in her career within the pharmaceutical industry. Her educational background supports her strong foundation in legal operations.
Achievements in Contract Management
Angelina Bellanton has successfully implemented Contract Lifecycle Management (CLM) systems in two organizations. This achievement highlights her capability in enhancing legal operations and streamlining contract processes. Her focus on improving operational efficiency has contributed to her reputation in the legal and pharmaceutical sectors.